Withholding or Withdrawing of Life-sustaining Therapy in Great East French Region Intensive Care Units: a 1-month Survey
LATA
1 other identifier
observational
78
1 country
1
Brief Summary
Intensive care has known an important scientists progress for the last twenty years, allowing to heal more and more severe patients. Throughout the time, population has been getting old more and more, making patients affected by several diseases. As any medical specialty, intensive care has been confronted to these both evolutions. Thus ethical issues subsist for many years concerning rationality of cares intensity given to the patients. Withholding or withdrawing of life-sustaining therapy represents a non-negligible part of deaths in intensive care units in France. Throughout the years, it has been more and more leading French laws, as the Clayes-Leonetti law, one of the most important and recent one, which has governed ending life patients' rights since 2016. Thus it appears interesting to propose this study to evaluate proportion of withholding or withdrawing of life-sustaining therapy and their conditions of setting up in a maximum of intensive care units in the Grand-Est region in France in 2022 ; and to collect family's feelings concerning these decisions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 18, 2022
CompletedFirst Posted
Study publicly available on registry
July 19, 2022
CompletedStudy Start
First participant enrolled
April 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 2, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 2, 2023
CompletedFebruary 7, 2025
February 1, 2025
7 months
July 18, 2022
February 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of withholding or withdrawing of life-sustaining therapy
The primary outcome measure will consist in determine the part of withholding or withdrawing of life-sustaining therapy measures in Grand Est French ICU to learn about their importance. Thus we can compare it to data we know from previous studies first. Second, we can evaluate the evolution throughout the time if there is one and the impact of new laws for example.
Day 28
Secondary Outcomes (3)
Conditions of setting up withholding or withdrawing of life-sustaining therapy
during the month of study
Agreement of these decisions with currently French legislation (" Claeys-Leonetti " lay, 2016)
at the inclusion of the patients in the study
Questionnaire Family Satisfaction with ICU - 24Revisited
during the month of study
Study Arms (1)
Patients
Adults patients aged for more than 18 years old, admitted in an intensive care unit in Grand-Est region in France, for whom a decision of withholding or withdrawing of life-sustaining therapy is taken during the month of study.
Interventions
Eligibility Criteria
Adults patients aged for more than 18 years old hospitalized in an intensive care unit in Grand-Est region in France during the month of study, for whom a decision of withholding or withdrawing of life-sustaining therapy is taken during the month of study. Contentment of the patient or their confident person must be collected to allow inclusion.
You may qualify if:
- Adults patients hospitalized in an intensive care unit in Grand-Est region in France
- For whom a decision of withholding or withdrawing of life-sustaining therapy is taken during the month of study
- Contentment of the patient or their support person collected.
You may not qualify if:
- Patients aged less than 18 years old
- Who already have a decision of withholding or withdrawing of life-sustaining therapy taken before the beginning of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimslead
Study Sites (1)
Damien JOLLY
Reims, France
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 18, 2022
First Posted
July 19, 2022
Study Start
April 3, 2023
Primary Completion
November 2, 2023
Study Completion
November 2, 2023
Last Updated
February 7, 2025
Record last verified: 2025-02